| ADVANCE trial results suggest that intensive glucose control slows progression to ESRD in diabetic patients. |
|
| Med Page Today: Over a mean follow up of five years, those on intensive glucose control had a significant 65% decreased risk of ESRD, compared with those on standard glucose-lowering therapy, Sophia Zoungas, MD, PhD, of the University of Sydney in Australia, reported during an oral session at the European Association for the Study of Diabetes meeting here. |